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prostate cancer. The major expected benefit of PGS should be a 
reduction of the high-dose levels to the rectal wall, rather than a 
prostate spatial fixation by-standing effect. 
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Purpose/Objective: Prostate patients at our hospital are treated to 
74Gy using a full-bladder drinking protocol, which is intended to 
improve seminal vesicle stability and reduce dose to bowel and 
bladder. Tomotherapy Planned Adaptive (TomoPA) permits dose 
distribution evaluation using daily MVCT imaging and is frequently 
used to assess the dosimetric impact of subjectively-defined 
incompliance with the drinking protocol. To optimise the clinical 
workflow, a simple, consistent method is needed to identify situations 
in which plan adaptation may be required. 
Materials and Methods: For each of 6 prostate patients receiving 
Tomotherapy,selected due to poor compliance with drinking protocol, 
4 MVCT scans showing large reductions in bladder volume were 
transferred to TomoPA. Bladder and bowel were contoured on the 
MVCT and the dose distribution recalculated. Compliance with 
PIVOTAL Trial protocol constraints was quantified. A single observer 
investigated various potential metrics (i.e. absolute and relative 
reductions in (i) bladder volume and (ii)bladder extension superior to 
prostate apex) to determine the optimal criteria for referral to 
TomoPA. 
Results: 5/24 MVCT scans were rejected due to limited scan length 
rendering identification of relevant bladder and bowel unreliable. In 
the remaining 19 scans, the lower dose PIVOTAL bowel constraints 
(i.e. V45<158cc,V50<110cc, V55<28cc) were always met, regardless of 
bladder volume reduction, while higher dose constraints (i.e. 
V60<6cc, V65=0cc) were exceeded only twice, in the same patient. 
‘Mandatory’ bladder tolerances (i.e.V65<50%, V70<30%) were 
exceeded in only 2/19 instances, although failure to meet ‘optimal’ 
constraints (V50<50%, V60<25%, V70<5%) was widespread in this 
cohort. The 1cm PTV margins adequately enclosed the seminal 
vesicles (>56.2Gy) in all cases. No metric consistently predicted 
dosimetric impact, although>50% bladder volume reduction from 
initial planning CT appeared to coincide with sharp increases in dose 
for both bowel (see figure) and bladder. Bladder volume could be 
measured for this purpose with an abdominal ultrasound probe prior 
to the patient entering the treatment room. Potential use of linear 
change in bladder extension, (ruler measurement on the MVCT image) 
as a predictive metric that would be easily identifiable prior to 
treatment and require minimal additional time, warrants further 
study, although the current cohort did not demonstrate a strong 
correlation in this regard. 
 
  
Conclusions: Tomotherapy prostate plans appear robust to large 
bladder volume changes, with dosimetric tolerances exceeded in only 
a few extreme cases. A bladder volume reduction >50% suggests that 
dosimetric evaluation may be warranted, although confirmation on a 
larger cohort is required prior to clinical implementation. 
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Purpose/Objective: The purpose of this study is to evaluate an offline 
adaptive IGRT protocol. Kilovoltage cone-beam CTs (CBCT) acquired 
during the first radiotherapy treatment sessions were used to adapt 
the PTV individually to variable organ filling and variation in 
positioning. Variation in rectum dose was studied. 
Materials and Methods: Eighteen patients post-prostatectomy with 
biochemical or macroscopic relapse in the prostate bed and two 
patients with localized prostate cancer, who underwent primary 3D 
conformal radiotherapy, were evaluated. The patients received 66.6 
to 76.2Gy (1.8Gy x 5weekly). All patients started radiotherapy with a 
4 field box technique to at least 18Gy. Then the treatment was 
continued with a VMAT technique on either the same or the modified 
PTV. The kV-CBCTs acquired in the first three fractions were 
transferred to the planning systems (Masterplan, Nucletron 
Netherlands and Eclipse, Varian Palo Alto CA) and registered with the 
planning CT. The rectum was delineated in all CBCTs (from below 
sigmoid flexure to above anal verge) and transferred to the planning 
CT. The PTV was adapted taking significant variation in organ filling 
and positioning into account. For planning CT and CBCTs V35 and V60 
(volume of organ in % that achieved 35Gy or 60Gy) for rectum were 
evaluated. The maximum dose to femoral head and femoral neck 
were evaluated in the planning CT. The modification of the PTV was 
estimated. 
Results: Variability of rectum during radiotherapy treatment 
influences the final administered rectum dose in comparison to 
planning CT and may influence the PTV. After the evaluation of the 
CBCTs, the PTV was modified for 15 of 20 patients. The changes of 
PTV had a range of 82 to -31cm³. Four PTVs were enlarged and nine 
reduced. The mean change of volume was 21cm³ with a standard 
deviation of 20cm³. In the planning CT the mean V35 for rectum over 
all patients was 52% with a standard deviation of 11%. The mean 
individual changes of V35 in planning CT and CBCTs for the rectum 
were 39 to 80% with a standard deviation of 1 to 13%. The maximal 
dose to femoral heads was 42Gy with a standard deviation of 9Gy. 
Conclusions: An evaluation of rectum volumes in the CBCTs of the 
first IGRT treatments results in a more realistic estimation of rectal 
dose and makes an adaptation of the PTV to individual variability in 
organ fillings and positioning uncertainties feasible. Commencing 
prostate treatments with a box technique and changing to a VMAT 
technique, after the PTV modification, is less time-consuming and still 
enables constrains for organs at risk to be fulfilled. 
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Purpose/Objective: To evaluate the need to correct full daily 
variation in patient anatomy and set-up when intensity-modulated 
radiotherapy (IMRT) is delivered in prostate and head and neck cancer 
patients with the Protura 6 DOF robotic couch (CIVCO Medical 
Solution). 
Materials and Methods: Prostate and H&N cancer patients treated 
with IMRT were selected for this study. Before starting radiation 
treatment each patient underwent a CT scan for radiotherapy 
planning. Prostate cancer patients were simulated in supine position 
with the dual leg CIVCO support system; conventional thermoplastic 
masks were used for immobilization of H&N patients. All patients 
received a daily CBCT before treatment to display the patient position 
and to detect necessary corrections. Geometrical shifts (3-Traslational 
and 3-Rotational) were identified by manual and/or automatic 3D 
match (Varian 6D Online Review System) and were then applied to the 
Protura 6 DOF robotic couch and recorded. Mean translational and 
rotational corrections and the/a 3D vector of displacement were 
calculated. 
Results: From October to December 2012, 5 prostate and 3 H&N 
patients were included in this ongoing study. One hundred and sixty 
CBCT studies were analyzed and compared. The mean (±SD) 
interfraction displacement of the translational corrections for 
prostate vs H&N patients were -0.2 ± 0.3 vs 0,1 ± 0,2 cm, 0.0 ± 0.3 vs 
0,2 ± 0,2 cm and -0.2 ± 0.5 vs 0,0 ± 0,3 cm in vertical, lateral and 
longitudinal direction. We observed a maximal translation shift (MTS) 
